Edgen Stock·Sep 18 2025, 13:43Back
K36 Therapeutics Advances Multiple Myeloma Therapy with Bristol Myers Squibb Collaboration
Edgen Stock·Sep 18 2025, 13:43
[1] K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma (https://finance.yahoo.com/news/k36-therapeuti ...)[2] K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma | Morningstar (https://vertexaisearch.cloud.google.com/groun ...)[3] Bristol Myers Squibb Reports First Quarter Financial Results for 2025 (https://vertexaisearch.cloud.google.com/groun ...)
